MAURELLI, MARTINA
 Distribuzione geografica
Continente #
NA - Nord America 865
EU - Europa 733
AS - Asia 285
OC - Oceania 8
SA - Sud America 3
Totale 1.894
Nazione #
US - Stati Uniti d'America 858
CN - Cina 176
IT - Italia 146
IE - Irlanda 142
GB - Regno Unito 115
SE - Svezia 109
FR - Francia 99
DE - Germania 58
SG - Singapore 50
FI - Finlandia 23
JP - Giappone 14
UA - Ucraina 13
IN - India 11
AU - Australia 7
IR - Iran 7
NL - Olanda 7
BE - Belgio 6
KR - Corea 5
TR - Turchia 5
ID - Indonesia 4
MX - Messico 4
CA - Canada 3
ES - Italia 3
LK - Sri Lanka 3
VN - Vietnam 3
CL - Cile 2
HK - Hong Kong 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BR - Brasile 1
CH - Svizzera 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
LU - Lussemburgo 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RS - Serbia 1
Totale 1.894
Città #
Chandler 244
Dublin 130
Ashburn 100
Southend 87
Beijing 60
Jacksonville 42
Lawrence 34
Princeton 34
New York 28
Wilmington 28
Verona 26
Singapore 23
Sindelfingen 20
Woodbridge 19
Washington 18
Helsinki 16
Monza 16
Jinan 14
Milan 12
Seattle 12
Bethnal Green 11
Ann Arbor 10
Houston 10
Bologna 9
Los Angeles 9
Dongguan 8
Frankfurt am Main 8
Nanjing 8
Redwood City 8
Chieri 7
Fairfield 7
Rome 7
Bari 5
Brindisi 5
Redmond 5
Shenyang 5
Brussels 4
Changsha 4
Ghaziabad 4
Hebei 4
Jiaxing 4
Kent 4
Konya 4
Nanchang 4
Amsterdam 3
Canberra 3
Colombo 3
Dearborn 3
Esslingen am Neckar 3
Fuzhou 3
Guangzhou 3
Hangzhou 3
Kolkata 3
Lappeenranta 3
Ningbo 3
Norwalk 3
Oakland 3
Oullins 3
Povegliano Veronese 3
Shahr-e Kord 3
Shanghai 3
Tianjin 3
Zhengzhou 3
Atlanta 2
Bangkok 2
Baoding 2
Barcelona 2
Binasco 2
Bratislava 2
Brisbane 2
Busto Arsizio 2
Cambridge 2
Casagiove 2
Chicago 2
Falconara Marittima 2
Florence 2
Gangbuk-gu 2
Genoa 2
Glasgow 2
Guadalajara 2
Haikou 2
Hanover 2
Honchō 2
Isorella 2
Jumet 2
Latiano 2
Le Mans 2
Leawood 2
Legnago 2
Lugo 2
Malang 2
Marana 2
Menlo Park 2
Monterrey 2
New Delhi 2
Phoenix 2
Seoul 2
Shimoishiwara 2
Shinchiba 2
Taiyuan 2
Totale 1.248
Nome #
A risankizumab super responder profile identified by long-term real-life observation-IL PSO (ITALIAN LANDSCAPE PSORIASIS) 121
null 80
Incidence and ten-year follow-up of primary cutaneous lymphomas: a single-centre cohort study 76
BRAF V600E expression in juvenile xanthogranuloma occurring after Langerhans cell histiocytosis. 61
Neutrophilic figurate erythema: report of a new case in an adult and comparison between adult and paediatric cases 57
Amicrobial Pustulosis of the Folds: Report of Three New Cases 57
Clinical and immunological profile of patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid 54
Psoriasin (S100A7) is increased in serum of patients with moderate to severe psoriasis 53
A systematic review of treatments for pityriasis lichenoides 52
Acquired perforating dermatoses show increased levels of cutaneous advanced glycation end-products 50
Idiopathic lichenoid and granulomatous dermatitis 50
Primary Cutaneous CD4+ Small/Medium Pleomorphic T-Cell Lymphoproliferative Disorder: A Case Series 49
Clinical features and treatments of transient acantholytic dermatosis (Grover’s disease): a systematic review 49
Dupilumab improves clinical manifestations, symptoms, and quality of life in adult patients with chronic nodular prurigo 48
Persistent localized hypertrichosis in a Caucasian child at sites of DTPa and chickenpox vaccination 47
Interferon-beta injection site reactions in patients with multiple sclerosis. 46
Alopecic and aseptic nodules of the scalp: A new case with a systematic review of the literature 46
Adrenergic urticaria successfully treated with omalizumab 43
Annular Erythema: New and Revisited Variants 42
Severe cutaneous aluminum reaction to quadrivalent human papillomavirus vaccine treated with cyclosporin 41
Biological agents targeting interleukin-13 for atopic dermatitis 41
Annually Recurring Erythema Annulare Centrifugum: A New Case Series with Review of the Literature 40
Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines 40
Milia-like calcinosis cutis in Down syndrome: a new case with a review of the literature 38
A case of genital primary syphilis with superimposed impetigo 37
Drug survival of dupilumab compared to cyclosporin in moderate-to-severe atopic dermatitis patients 37
Clinical profile and co-infections of urethritis in males 37
Cost per Responder Analysis of Secukinumab versus Adalimumab in the Treatment of Psoriatic Disease 37
IL-17A inhibitors in patients with chronic plaque psoriasis and history of malignancy: A case series with systematic literature review 34
Eosinophilic annular erythema successfully treated with cyclosporine 31
Palisaded neutrophilic granulomatous dermatitis and its associations with autoimmune diseases 31
Lichen planopilaris coexisting with plaque psoriasis effectively treated with brodalumab 29
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis 28
A man with a widespread bullous eruption 26
Uncommon Non‑Infectious Annular Dermatoses 26
Visual Vignette 26
Targeting IL-4 for the Treatment of Atopic Dermatitis 25
Cost per responder of Adalimumab biosimilars MSB11022 and ABP 501 versus the originator and methotrexate in chronic plaque psoriasis 23
The emerging role of the neuroimmune cytokine interleukin-31 in chronic inflammatory skin diseases 23
Pruritus as a Distinctive Feature of Type 2 Inflammation 23
Variations of symptoms of atopic dermatitis and psoriasis in relation to menstrual cycle 19
Lymphoplasmacytic plaque effectively treated with imiquimod 19
Atopic Dermatitis in the Elderly Population 17
Advanced Glycation End Products and Psoriasis 17
Is risankizumab as needed administration a good option for patients with plaque psoriasis? 17
Advanced Glycation End Products are Increased in the Skin and Blood of Patients with Severe Psoriasis 16
Reduction of cutaneous advanced glycation end products levels after effective psoriasis treatment 16
Tailored biological treatment for patients with moderate-to-severe psoriasis 14
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis 13
The Combination of Dupilumab with Other Monoclonal Antibodies 12
Cost per responder of adalimumab biosimilars versus methotrexate in patients with psoriasis: a real-life experience 10
Price variability of TNF-α inhibitor biosimilars among European countries 10
Overview of Atopic Dermatitis in Different Ethnic Groups 8
Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study 8
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study—IL PSO (ITALIAN LANDSCAPE PSORIASIS) 5
Managing the Patient with Psoriasis and Metabolic Comorbidities 4
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study 4
Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis 3
Totale 1.966
Categoria #
all - tutte 9.896
article - articoli 9.703
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 193
Totale 19.792


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202092 7 2 1 0 21 10 2 2 5 13 16 13
2020/2021127 13 13 3 21 19 16 10 1 6 2 13 10
2021/2022228 13 26 0 18 31 6 6 23 4 14 30 57
2022/2023738 38 68 63 134 58 187 16 34 90 13 25 12
2023/2024644 16 30 56 51 52 126 115 42 8 39 71 38
Totale 1.966